Wall Street Analysts Think Janux Therapeutics (JANX) Could Surge 40.3%: Read This Before Placing a Bet

Shares of Janux Therapeutics, Inc. (JANX) have gained 11.8% over the past four weeks to close the last trading session at $44.62, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $62.60 indicates a potential upside of 40.3%.The mean estimate comprises five short-term price targets with a standard deviation of $21.58. While the lowest estimate of $48 indicates a 7.6% increase from ...